Stratmann, Jan A.; Althoff, Friederike C.; Doebel, Paula et al.
Sotorasib in<i> KRAS</i> G12C-mutated non-small cell lung cancer: A multicenter real-world experience from the compassionate use program in GermanyEUROPEAN JOURNAL OF CANCER. Bd. 201. 2024
Vinnakota, Janaki Manoja; Biavasco, Francesca; Schwabenland, Marius et al.
Targeting TGFβ-activated kinase-1 activation in microglia reduces CAR T immune effector cell-associated neurotoxicity syndromeNATURE CANCER. Bd. 5. H. 8. 2024
Beier, Alicia-Marie K.; Ebersbach, Celina; Siciliano, Tiziana et al.
Targeting the glutamine metabolism to suppress cell proliferation in mesenchymal docetaxel-resistant prostate cancerONCOGENE. Bd. 43. H. 26. 2024 S. 2038-2050
Amann, Elisa Maria; Gowdavally, Sowmya; Tsamadou, Chrysanthi et al.
The impact of MICB mismatches in unrelated haematopoietic stem cell transplantationHLA. Bd. 103. H. 6. 2024
Kuehn, Michael W. M.; Ganser, Arnold
The Menin story in acute myeloid leukaemia-The road to successBRITISH JOURNAL OF HAEMATOLOGY. Bd. 205. H. 3. 2024 S. 812-814
Brandt, Anna; Schultheiss, Christoph; Klinghammer, Konrad et al.
Tolerability and efficacy of the cancer vaccine UV1 in patients with recurrent or metastatic PD-L1 positive head and neck squamous cell carcinoma planned for first-line treatment with pembrolizumab - the randomized phase 2 FOCUS trialFRONTIERS IN ONCOLOGY. Bd. 14. 2024
Ayuk, Francis; Wagner-Drouet, Eva-Maria; Wolff, Daniel et al.
Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA studyBONE MARROW TRANSPLANTATION. Bd. 59. H. 8. 2024 S. 1092-1096
Naveja, JJ; Saldivar-Gonzalez, F; Prado-Romero, D. L. et al.
Visualization, Exploration, and Screening of Chemical Space in Drug DiscoveryVasanthanathan Poongavanam, Vijayan Ramaswamy (Hrsg). Computational Drug Discovery: Methods and Applications. Wiley Online Library 2024
Pretzell, Ina; Desuki, Alexander; Bleckmann, Annalen et al.
What Do German Molecular Tumor Boards Recommend in Patients with PIK3CA-Mutated Tumors? Launch and First Results from the German Transsectoral Molecular Tumor Board Exchange Platform DeutschlandONCOLOGY RESEARCH AND TREATMENT. Bd. 47. H. 9. 2024
Nowakowski, Grzegorz S.; Yoon, Dok Hyun; Mondello, Patrizia et al.
& nbsp;RE-MIND2: comparative effectiveness of tafasitamab plus lenalidomide versus polatuzumab vedotin/bendamustine/rituximab (pola-BR), CAR-T therapies, and lenalidomide/rituximab (R2) based on real-world data in patients with relapsed/refractory diffuse large B-cell lymphoma (vol 102, pg 1773, 2023)ANNALS OF HEMATOLOGY. 2023